Success Metrics

Clinical Success Rate
95.6%

Based on 43 completed trials

Completion Rate
96%(43/45)
Active Trials
4(6%)
Results Posted
23%(10 trials)
Terminated
2(3%)

Phase Distribution

Ph not_applicable
14
23%
Ph phase_2
9
15%
Ph phase_1
2
3%
Ph phase_4
18
29%
Ph phase_3
14
23%
Ph early_phase_1
4
6%

Phase Distribution

6

Early Stage

9

Mid Stage

32

Late Stage

Phase Distribution61 total trials
Early Phase 1First-in-human
4(6.6%)
Phase 1Safety & dosage
2(3.3%)
Phase 2Efficacy & side effects
9(14.8%)
Phase 3Large-scale testing
14(23.0%)
Phase 4Post-market surveillance
18(29.5%)
N/ANon-phased studies
14(23.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.5%

43 of 46 finished

Non-Completion Rate

6.5%

3 ended early

Currently Active

4

trials recruiting

Total Trials

62

all time

Status Distribution
Active(6)
Completed(43)
Terminated(3)
Other(10)

Detailed Status

Completed43
unknown10
Recruiting3
Not yet recruiting2
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
62
Active
4
Success Rate
95.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (6.6%)
Phase 12 (3.3%)
Phase 29 (14.8%)
Phase 314 (23.0%)
Phase 418 (29.5%)
N/A14 (23.0%)

Trials by Status

completed4369%
withdrawn12%
not_yet_recruiting23%
active_not_recruiting12%
recruiting35%
terminated23%
unknown1016%

Recent Activity

Clinical Trials (62)

Showing 20 of 62 trialsScroll for more
NCT04699357Not Applicable

The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Randomized Clinical Trial

Completed
NCT07095894Phase 3

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

Not Yet Recruiting
NCT07367178Phase 2

Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer

Not Yet Recruiting
NCT06579287Phase 2

A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control

Active Not Recruiting
NCT00992901Early Phase 1

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Recruiting
NCT02823665Early Phase 1

The Effects of Bariatric Surgeries on Glucose Metabolism

Recruiting
NCT05815784Phase 2

Myopia Control: a Comparison Study Between Atropine and MiSight

Recruiting
NCT06111352Phase 2

Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime

Completed
NCT01871922Not Applicable

Atropine-effect During Propofol/Remifentanil Induction

Completed
NCT03334253Phase 3

Low-Dose Atropine for Treatment of Myopia

Completed
NCT05658380Phase 3

Impact of Pre-spinal Atropine on Post Spinal Hemodynamics and Cardiac Output Measured by Electrical Cardiometry in Caesarean Delivery

Completed
NCT01819064Phase 4

Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants

Completed
NCT05203432Not Applicable

Red Light Intervention on Myopic Progression

Unknown
NCT05006638Phase 4

Assessing The Role Of Intravenous Lipid Emulsion As A Life Saving Therapy In Pesticides Toxicity

Unknown
NCT03972683Early Phase 1

Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training

Withdrawn
NCT04777383Not Applicable

The Effects of Iontophoresed Vasoactive Drugs on Cutaneus Blood Flow

Unknown
NCT02870478Phase 3

The Effects of Low Concentration Atropine on Pupil Size and Accommodation

Completed
NCT02927223Not Applicable

Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Completed
NCT02839668Phase 2

The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)

Completed
NCT02726620Not Applicable

Decision Support for Intraoperative Low Blood Pressure

Completed

Drug Details

Intervention Type
DRUG
Total Trials
62